Emmaus Life Sciences Inc (OTCQX:EMMA) announced that the Kuwaiti Ministry of Health has granted marketing authorization for the commercial distribution and.
/PRNewswire/ Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, announced today that it has received Registration Approval.